Difficulty: Medium
Average Score: 69%
Practice
In patients with Parkinson's disease, histologic studies suggest an imbalance in brain neurotransmitters. In contrast to normal individuals, the patients with Parkinson's disease have an abundance of which of the following neurons and associated neurotransmitters?
Correct answer
A
Rationale
In Parkinson's disease, there is a decrease in dopamine-producing neurons in the substantia nigra region of the brain. This results in an imbalance between dopamine and acetylcholine, leading to motor symptoms characteristic of the disease. Therefore, patients with Parkinson's disease have an abundance of acetylcholine compared to dopamine.
Option A, acetylcholine, is the correct answer because of the dopaminergic deficit in Parkinson's disease. Acetylcholine levels are relatively increased due to the lack of dopamine regulation.
Options B, C, and D are incorrect:
- Dopamine (Option B) is actually decreased in patients with Parkinson's disease, leading to the characteristic motor symptoms.
- Epinephrine (Option C) and norepinephrine (Option D) are not directly implicated in the pathophysiology of Parkinson's disease and are not found in abundance in these patients.
Understanding the neurotransmitter imbalances in Parkinson's disease is crucial for healthcare providers as it guides the selection of appropriate pharmacological agents for treatment. This knowledge is fundamental for nurses, pharmacists, and other healthcare professionals involved in the care of patients with Parkinson's disease.
Option A, acetylcholine, is the correct answer because of the dopaminergic deficit in Parkinson's disease. Acetylcholine levels are relatively increased due to the lack of dopamine regulation.
Options B, C, and D are incorrect:
- Dopamine (Option B) is actually decreased in patients with Parkinson's disease, leading to the characteristic motor symptoms.
- Epinephrine (Option C) and norepinephrine (Option D) are not directly implicated in the pathophysiology of Parkinson's disease and are not found in abundance in these patients.
Understanding the neurotransmitter imbalances in Parkinson's disease is crucial for healthcare providers as it guides the selection of appropriate pharmacological agents for treatment. This knowledge is fundamental for nurses, pharmacists, and other healthcare professionals involved in the care of patients with Parkinson's disease.